This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andre Kiryanov and His Patent on Orexin Receptor Agonists.
Introduction
Andre Kiryanov is an inventor associated with Takeda Pharmaceutical Company Limited. His patent work concerns a potential treatment for narcolepsy through compounds that activate the orexin type 2 receptor.
Latest Patents
Kiryanov is associated with 1 patent: “Macrocyclic Heterocycle Compounds and Use Thereof.” The invention describes heterocyclic compounds, or their salts, with orexin type 2 receptor agonist activity. The patent identifies these compounds as potential agents for the prevention or treatment of narcolepsy.
Career Highlights
Kiryanov’s listed patent reflects research into pharmaceutical compounds and their possible therapeutic applications. The available information associates his work with Takeda Pharmaceutical Company Limited.
Collaborations
Mitsunori Kono and Yusuke Sasaki are identified as Kiryanov’s coworkers.
Conclusion
Andre Kiryanov’s patent contribution focuses on orexin type 2 receptor agonists and their potential use in addressing narcolepsy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile